Concepedia

S. Pollack

SP

Statistics

Publications

1

Citations

11

H-Index

1

Active since

2024

Affiliations

The Ohio State University(Current)

S. Pollack is an author at The Ohio State University specializing in targeted cancer therapy, chemotherapy, and targeted therapy.

Publications per year

2024–2024

1

Publications

1

53O Results from a phase II part I trial of mecbotamab vedotin (BA3011), a CAB-AXL-ADC, in patients with advanced refractory sarcoma

S. Pollack, A.P. Conley, William D. Tap et al. · ESMO Open · 2024 · 11 citations · Full text

, , +17

1–1 of 1